Healthcare - Medical - Devices - NASDAQ - US
$ 2.84
-8.97 %
$ 13.5 M
Market Cap
-0.42
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
57.13%
EBIT
Estimate
--21.54%
Net Income
Estimate
86.44%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vivos Therapeutics, Inc.
VVOS has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart VVOS
EBIT FORECAST
EBIT Forecast Chart VVOS
NET INCOME FORECAST
Net Income Chart VVOS